+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 61 Pages
  • December 2024
  • GlobalData
  • ID: 4437278
Azenta Inc (AZTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Azenta Inc (Azenta), formerly Brooks Automation Inc, provides sample exploration and management solutions for the life sciences industry. The company’s product portfolio includes automated storage systems, vaccine cold storage and transport, genomic services, and sample management solutions. It also offers services supporting customers at every stage of the life cycle of samples including procurement and a multitude of sample consumables, informatics and data software, along with sample repository services. Azenta's offerings find application in pharmaceutical, biotechnology, and life sciences research institutions. The company operates through manufacturing facilities in Missouri, the US; Manchester, the UK; and Hosingen, Luxembourg. Azenta is headquartered in Burlington, Massachusetts, the US.

Azenta Inc Key Recent Developments

  • Nov 12, 2024: Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
  • Nov 04, 2024: Azenta Announces Appointment of New Independent Directors to Board
  • Sep 04, 2024: Azenta Announces Addition of John Marotta as CEO
  • Sep 04, 2024: Azenta Appoints John Marotta as CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Azenta Inc - Key Facts
  • Azenta Inc - Key Employees
  • Azenta Inc - Key Employee Biographies
  • Azenta Inc - Major Products and Services
  • Azenta Inc - History
  • Azenta Inc - Company Statement
  • Azenta Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Azenta Inc - Business Description
  • Business Segment: Life Sciences Products
  • Overview
  • Performance
  • Business Segment: Life Sciences Services
  • Overview
  • Performance
  • Geographical Segment: Africa
  • Performance
  • Geographical Segment: Asia/Pacific/Other
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Rest of Europe
  • Performance
  • Geographical Segment: United Kingdom
  • Performance
  • R&D Overview
  • Azenta Inc - Corporate Strategy
  • Azenta Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Azenta Inc - Strengths
  • Azenta Inc - Weaknesses
  • Azenta Inc - Opportunities
  • Azenta Inc - Threats
  • Azenta Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Azenta Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 12, 2024: Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
  • Nov 04, 2024: Azenta Announces Appointment of New Independent Directors to Board
  • Sep 04, 2024: Azenta Announces Addition of John Marotta as CEO
  • Sep 04, 2024: Azenta Appoints John Marotta as CEO
  • Jul 24, 2024: Brooks Automation to Showcase Innovative Hybrid Lab Automation Solutions at the Association for Diagnostics and Laboratory Medicine Conference (ADLM) July 30-August 1 in Chicago
  • Jul 24, 2024: Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
  • Jul 22, 2024: FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
  • Jun 04, 2024: Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
  • May 14, 2024: Azenta deepens UK reach with opening of Oxford genomic lab
  • May 09, 2024: Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Azenta Inc, Key Facts
  • Azenta Inc, Key Employees
  • Azenta Inc, Key Employee Biographies
  • Azenta Inc, Major Products and Services
  • Azenta Inc, History
  • Azenta Inc, Other Locations
  • Azenta Inc, Subsidiaries
  • Azenta Inc, Key Competitors
  • Azenta Inc, Ratios based on current share price
  • Azenta Inc, Annual Ratios
  • Azenta Inc, Interim Ratios
  • Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Azenta Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Azenta Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Azenta Inc, Performance Chart (2020 - 2024)
  • Azenta Inc, Ratio Charts
  • Azenta Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Azenta Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novogene Co Ltd
  • Eurofins Scientific SE
  • BGI Genomics Co Ltd
  • Laboratory Corp of America Holdings
  • Liconic AG
  • Integrated DNA Technologies Inc
  • Hamilton Company
  • Haier Biomedical HK Co., Limited
  • Genscript Biotech Corp
  • Thermo Fisher Scientific Inc
  • Vestfrost A/S
  • Twist Bioscience Corp